Document is current

Article History

Accepted: 12 August 2024

First Online: 20 September 2024

Funding

: Funding for this study was provided by Bristol Myers Squibb. Publication of results was not contingent on the sponsor’s approval or censorship of the manuscript.

: The lead author (NRL) has a role at the University of Sheffield that is funded by Yorkshire Cancer Research (award reference number S406NL), but this work was conducted in his time as a Delta Hat Ltd employee. SH, GO, CC, IK, JB and DB were employed by Bristol Myers Squibb during the conduct of the research for this article. JB was an author of the Palmer et al. paper that proposed the algorithm evaluated in the present study, and SH, GO, CC, IK and DB have been colleagues of JB at Bristol Myers Squibb. NRL has collaborated with authors of the Palmer et al. paper in previous research.

: Not applicable.

: Not applicable.

: Not applicable.

: The data used for our analyses were from CM-649 (NCT02872116), provided by Bristol Myers Squibb to Delta Hat Ltd via a data sharing agreement. Qualified researchers may request data from Bristol Myers Squibb clinical studies. Complete details are available at .

: Not applicable.

: All authors contributed to the study conception and design. Analysis was performed by NRL with support from KT. The first draft of the manuscript was written by NRL and all other authors critically revised the work. All authors read and approved the final manuscript.